The natural history of chronic hepatitis B virus infection

Journal of Clinical Virology

Volumn 34, Issue SUPPL. 1, 2005, Pages

  Villeneuve, Jean Pierre ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Antiviral treatment; Chronic hepatitis B; Cirrhosis; Hepatocellular carcinoma

Indexed keywords

ADEFOVIR; AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ACUTE HEPATITIS; ARTICLE; CHRONIC HEPATITIS; GLOMERULONEPHRITIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INCUBATION TIME; LEUKOCYTOCLASTIC VASCULITIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; POLYARTERITIS NODOSA; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION;

CARCINOMA, HEPATOCELLULAR; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS;

EID: 32044434943     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(05)80024-1     Document Type: Article

References (19)

1. Carman W.E., Jacyna M.R., Hadziyannis S., Karayiannis P., McGarvey M.J., Makris A., and Thomas H.C. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection Lancet 2 1989 588 591
2. De Jongh F.E., Janssen H.L., de Man R.A., Hop W.C., Schalm S.W., and van Blankenstein M. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver Gastroenteroloy 103 1992 1630 1635
3. Fattovich G., Brollo L., Giustina G., Noventa F., Pontisso P., and Alberti A. Natural history and prognostic factors for chronic hepatitis type B Gut 32 1991 294 298
4. Fattovich G., Giustina G., Schalm S.W., Hadziyannis S., Sanchez-Tapias J., and Almasio P. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis Hepatology 21 1995 77 82
5. Fattovich G., Rugge M., Brollo L., Pontisso P., Noventa F., and Guido M. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B Hepatology 6 1986 167 172
6. Hsu Y.S., Chien R.N., Yeh C.T., Sheen I.S., Chiou H.Y., and Chu C.M. Longterm outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B Hepatology 35 2002 1522 1527
7. Ikeda K., Saitoh S., Suzuki Y., Kobayashi M., Tsubota A., and Koida I. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients J Hepatol 28 1998 930 938
8. Kirk G.D., Lesi O.A., Mendy M., Akano A.O., Sam O., and Goedert J.J. The Gambia Liver Cancer Study: infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa Hepatology 39 2004 211 219
9. Laras A., Koskinas J., Avgidis K., and Hadziyannis S.J. Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients J Viral Hepatitis 5 1998 241 248
10. Lee W.M. Hepatitis B virus infection N Engl J Med 337 1997 1733 1745
11. Liaw Y.F., Chu C.M., Su I.J., Huang M.J., Lin D.Y., and Chang-Chien C.S. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis Gastroenterology 84 1983 216 219
12. Liaw Y.F., Sung J.J., Chow W.C., Farrell G., Lee C.Z., and Yuen H. Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 2004 1521 1531
13. Manno M., Camma C., Schepis F., Bassi F., Gelmini R., and Giannini F. Natural history of chronic HBV carrriers in northern Italy: morbidity and mortality after 30 years Gastroenterology 127 2004 756 763
14. Realdi G., Fattovich G., Hadziyannis S., Schalm S.W., Almasio P., and SanchezTapias J. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis. (EUROHEP) J Hepatol 21 1994 656 666
15. Schiff E.R., Lai C.L., Hadziyannis S., Neuhaus P., Terrault N., and Colombo M. Adefovir dipivoxil therapy for Lamivudine-resistant hepatitis B in preand post-liver transplantation patients Hepatology 38 2003 1419 1427
16. Shindo M., Hamada K., Koya S., Sokawa Y., and Okuno T. The clinical significance of core promoter and precoce mutations during the natural course and interferon therapy in patients with chronic hepatitis B Am J Gastroenterol 94 1999 237 245
17. Villeneuve J.P., Condreay L.D., Willems B., Pomier-Layrargues G., Fenyves D., and Bilodeau M. Lamivudine treatment for decompendated cirrhosis resulting from chronic hepatitis B Hepatology 31 2000 206 210
18. Villeneuve J.P., Desrochers M., Infante-Rivard C., Willems B., Raymond G., and Bourcier M. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal Gastroenteroly 106 1994 1000 1005
19. Yang H.I., Lu S.N., Liaw Y.F., You S.L., Sun C.A., and Wang L.Y. Hepatitis B e antigen and the risk of hepatocellular carcinoma N Engl J Med 347 3 2002 168 174